|
1
|
Jankovic J: Parkinson's disease: Clinical
features and diagnosis. J Neurol Neurosurg Psychiatry. 79:368–376.
2008.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Noorian AR, Rha J, Annerino DM, Bernhard
D, Taylor GM and Greene JG: Alpha-synuclein transgenic mice display
age-related slowing of gastrointestinal motility associated with
transgene expression in the vagal system. Neurobiol Dis. 48:9–19.
2012.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Chaudhuri KR and Schapira AH: Non-motor
symptoms of Parkinson's disease: Dopaminergic pathophysiology and
treatment. Lancet Neurol. 8:464–474. 2009.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Magerkurth C, Schnitzer R and Braune S:
Symptoms of autonomic failure in Parkinson's disease: Prevalence
and impact on daily life. Clin Auton Res. 15:76–82. 2005.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Fasano M and Lopiano L: Alpha-synuclein
and Parkinson's disease: A proteomic view. Expert Rev Proteomics.
5:239–248. 2008.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Tofaris GK, Razzaq A, Ghetti B, Lilley KS
and Spillantini MG: Ubiquitination of alpha-synuclein in Lewy
bodies is a pathological event not associated with impairment of
proteasome function. J Biol Chem. 278:44405–44411. 2003.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Spillantini MG, Schmidt ML, Lee VM,
Trojanowski JQ, Jakes R and Goedert M: Alpha-synuclein in Lewy
bodies. Nature. 388:839–880. 1997.PubMed/NCBI View
Article : Google Scholar
|
|
8
|
Tansey MG, McCoy MK and Frank-Cannon TC:
Neuroinflammatory mechanisms in Parkinson's disease: Potential
environmental triggers, pathways, and targets for early therapeutic
intervention. Exp Neurol. 208:1–25. 2007.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Saunders JA, Estes KA, Kosloski LM, Allen
HE, Dempsey KM, Torres-Russotto DR, Meza JL, Santamaria PM, Bertoni
JM, Murman DL, et al: CD4+ regulatory and effector/memory T cell
subsets profile motor dysfunction in Parkinson's disease. J
Neuroimmune Pharmacol. 7:927–938. 2012.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Brochard V, Combadière B, Prigent A,
Laouar Y, Perrin A, Beray-Berthat V, Bonduelle O, Alvarez-Fischer
D, Callebert J, Launay JM, et al: Infiltration of CD4+ lymphocytes
into the brain contributes to neurodegeneration in a mouse model of
Parkinson disease. J Clin Invest. 119:182–192. 2009.PubMed/NCBI View
Article : Google Scholar
|
|
11
|
Jiang L, Hu J, Feng J, Han D and Yang C:
Substrate stiffness of endothelial cells directs LFA-1/ICAM-1
interaction: A physical trigger of immune-related diseases? Clin
Hemorheol Microcirc. 61:633–643. 2016.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Harrer A, Pilz G, Wipfler P, Oppermann K,
Sellner J, Hitzl W, Haschke-Becher E, Afazel S, Rispens T, van der
Kleij D, et al: High interindividual variability in the CD4/CD8 T
cell ratio and natalizumab concentration levels in the
cerebrospinal fluid of patients with multiple sclerosis. Clin Exp
Immunol. 180:383–392. 2015.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Dickson DW: Parkinson's disease and
parkinsonism: neuropathology. Cold Spring Harb Perspect Med.
2(a009258)2012.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Meredith GE and Rademacher DJ: MPTP mouse
models of Parkinson's disease: An update. J Parkinsons Dis.
1:19–33. 2011.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Luchtman DW, Shao D and Song C: Behavior,
neurotransmitters and inflammation in three regimens of the MPTP
mouse model of Parkinson's disease. Physiol Behav. 98:130–138.
2009.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Deacon RM, Koros E, Bornemann KD and
Rawlins JN: Aged Tg2576 mice are impaired on social memory and open
field habituation tests. Behav Brain Res. 197:466–468.
2009.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Chandra G, Rangasamy SB, Roy A, Kordower
JH and Pahan K: Neutralization of RANTES and eotaxin prevents the
loss of dopaminergic neurons in a mouse model of parkinson disease.
J Biol Chem. 291:15267–15281. 2016.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Krummel MF, Bartumeus F and Gérard A: T
cell migration, search strategies and mechanisms. Nat Rev Immunol.
16:193–201. 2016.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Walling BL and Kim M: LFA-1 in T cell
migration and differentiation. Front Immunol. 9(952)2018.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Miklossy J, Doudet DD, Schwab C, Yu S,
McGeer EG and McGeer PL: Role of ICAM-1 in persisting inflammation
in Parkinson disease and MPTP monkeys. Exp Neurol. 197:275–283.
2006.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Rivera-Nieves J, Gorfu G and Ley K:
Leukocyte adhesion molecules in animal models of inflammatory bowel
disease. Inflamm Bowel Dis. 14:1715–1735. 2008.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Ivanov II, Atarashi K, Manel N, Brodie EL,
Shima T, Karaoz U, Wei D, Goldfarb KC, Santee CA, Lynch SV, et al:
Induction of intestinal Th17 cells by segmented filamentous
bacteria. Cell. 139:485–498. 2009.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Ivanov II, Frutos Rde L, Manel N,
Yoshinaga K, Rifkin DB, Sartor RB, Finlay BB and Littman DR:
Specific microbiota direct the differentiation of IL-17-producing
T-helper cells in the mucosa of the small intestine. Cell Host
Microbe. 4:337–349. 2008.PubMed/NCBI View Article : Google Scholar
|
